SALVADORI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 801
EU - Europa 611
AS - Asia 282
OC - Oceania 5
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.704
Nazione #
US - Stati Uniti d'America 801
IT - Italia 259
IE - Irlanda 145
SG - Singapore 115
HK - Hong Kong 54
CN - Cina 39
SE - Svezia 34
KR - Corea 26
AT - Austria 25
DE - Germania 21
RO - Romania 20
FR - Francia 16
FI - Finlandia 15
GB - Regno Unito 15
RU - Federazione Russa 14
BE - Belgio 12
PH - Filippine 11
CH - Svizzera 8
TR - Turchia 8
UA - Ucraina 8
NL - Olanda 7
AU - Australia 5
JP - Giappone 5
VN - Vietnam 5
IN - India 4
IR - Iran 4
PL - Polonia 4
BR - Brasile 3
ES - Italia 3
LB - Libano 3
CZ - Repubblica Ceca 2
PK - Pakistan 2
TW - Taiwan 2
UZ - Uzbekistan 2
CL - Cile 1
EU - Europa 1
GR - Grecia 1
IL - Israele 1
KH - Cambogia 1
MD - Moldavia 1
NO - Norvegia 1
Totale 1.704
Città #
Chandler 191
Dublin 142
Perugia 99
Singapore 99
San Mateo 56
Hong Kong 52
Boardman 50
Altamura 34
Ann Arbor 32
Redmond 31
Dearborn 28
Medford 28
Princeton 27
Vienna 24
Wilmington 22
Andover 20
Bucharest 19
Lawrence 18
Ashburn 16
Beijing 16
Santa Clara 14
Brussels 12
Falls Church 11
Parma 9
Los Angeles 8
Cebu City 7
Redwood City 7
Seodaemun-gu 7
Collazzone 6
Des Moines 6
Glasgow 6
Norwalk 6
Saint Petersburg 6
Dong Ket 5
Seoul 5
Helsinki 4
Karaj 4
Konya 4
Milan 4
Woodbridge 4
Xiamen 4
Amsterdam 3
Bologna 3
Cambridge 3
Delft 3
Dumaguete 3
Hachenburg 3
Houston 3
Istanbul 3
Macerata 3
Mumbai 3
Perth 3
Rimini 3
São Paulo 3
Villeurbanne 3
Cannara 2
Didcot 2
Dongjak-gu 2
Ealing 2
Florence 2
Jeju City 2
Jinan 2
Kinross 2
Kunming 2
Lugano 2
Mainz 2
Modena 2
Monreale 2
Moscow 2
New York 2
Nürnberg 2
Olomouc 2
Oneonta 2
Phoenix 2
Piemonte 2
Raisio 2
Seongnam-si 2
Sindelfingen 2
Turin 2
Turku 2
Wollongong 2
Yuseong-gu 2
Alviano 1
Assisi 1
Bergen 1
Capannelle 1
Changsha 1
Chicago 1
Chisinau 1
Città Di Castello 1
Costa Mesa 1
Dallas 1
Den Haag 1
Fossato Di Vico 1
Frankfurt Am Main 1
Fremont 1
Guangzhou 1
Guidonia 1
Gwanak-gu 1
Hebei 1
Totale 1.257
Nome #
Intraperitoneal injection of microencapsulated Sertoli cells restores muscle morphology and performance in dystrophic mice 117
RAGE in the pathophysiology of skeletal muscle. 99
Generation of an mdx/Ager–/– double mutant mouse. Preliminary data on skeletal muscle architecture. 88
Histological muscle characterization in hypertrophied Marchigiana cattle breed 87
Sertoli cells protect C2C12 myotubes against atrophy and induce utrophin expression in canine and human dystrophic myotubes. 87
Targeting RAGE as a potential therapeutic approach to Duchenne muscular dystrophy 76
RAGE and its ligands, S100B and HMGB1, are molecular determinants of cancer-induced muscle wasting. 70
Toward the identification of receptor for advanced glycation end-products (RAGE) as a muscle biomarker of cancer cachexia. 70
Effects of intraperitoneal injection of microencapsulated Sertoli cells on chronic and presymptomatic dystrophic mice 65
Screening of 100 plant extracts for the development of a herbal product effective against muscle atrophy 64
Employment of Microencapsulated Sertoli Cells as a New Tool to Treat Duchenne Muscular Dystrophy 62
Sertoli cell-secreted factors have promyogenic and antifibrotic properties on human DMD myoblasts with different mutations. 60
Microencapsulated Sertoli cells sustain myoblast proliferation without affecting the myogenic potential. In vitro data 59
Natural products to counteract muscle atrophy 57
The receptor RAGE: a potential molecular target in cancer cachexia 56
Do porcine Sertoli cells represent an opportunity for Duchenne muscular dystrophy? 55
Mdx/Ager–/– mice show reduced muscle necrosis and inflammation compared with mdx mice 53
Use of Sertoli cells to treat DMD patients is supported by their immunomodulatory rather than immunosuppressive effect 51
Absence of RAGE in an animal experimental model of Duchenne muscular dystrophy results in reduced muscle necrosis and inflammation 50
The novel DMD experimental model, mdx/Ager–/– mouse reveals a role of RAGE in inflammatory processes in dystrophic muscles. 43
Novel data support the use of microencapsulated Sertoli cells as a potential treatment of DMD patients. 43
Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia 42
Hyperactivated rage in comorbidities as a risk factor for severe covid-19—the role of rage-ras crosstalk 42
Involvement of a RAGE/p38MAPK/myogenin axis in cancer cachexia. 41
Receptor for advanced glycation end-products (RAGE) as a biomarker of muscle wasting in cancer conditions 36
Identification of Withania somnifera-Silybum marianum-Trigonella foenum-graecum Formulation as a Nutritional Supplement to Contrast Muscle Atrophy and Sarcopenia 36
Beneficial effects of horsetail (Equisetum arvense) in experimental models of sarcopenia and osteoporosis 27
Equisetum arvense standardized extract hinders age-related sarcopenia 26
KYMASIN UP Natural Product Inhibits Osteoclastogenesis and Improves Osteoblast Activity by Modulating Src and p38 MAPK 25
Pharmacological targeting of the receptor for advanced glycation end-products (RAGE) to counteract cancer cachexia 24
Sertoli cells improve myogenic differentiation, reduce fibrogenic markers, and induce utrophin expression in human dmd myoblasts 24
Identification of natural products able to counteract the formation of advanced glycation end-products (AGEs) sustaining muscle atrophy 20
Ablation of RAGE (receptor for advanced glycation end-products) translates into reduced tumorigenic and cachectic potential in LLC-tumor bearing mice 19
Equisetum arvense standardized dried extract hinders age-related osteosarcopenia. 14
Sertoli cells induce utrophin expression in human DMD myotubes with different mutations and exert promyogenic and antifibrotic effects 12
Beneficial effects of horsetail (Equisetum arvense) in in vitro models of sarcopenia and osteoporosis 8
Sertoli cells have promyogenic and antifibrotic effects, and induce utrophin expression in human DMD myotubes with different mutations in a heregulin β1/ErbB2/ERK1/2-dependent manner 7
Grafted Sertoli Cells Exert Immunomodulatory Non-Immunosuppressive Effects in Preclinical Models of Infection and Cancer 7
Totale 1.822
Categoria #
all - tutte 7.324
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.324


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020129 0 0 0 3 9 21 19 3 56 16 1 1
2020/2021155 1 4 10 4 62 21 24 2 10 8 3 6
2021/2022290 3 40 9 17 6 8 8 75 10 32 43 39
2022/2023548 30 104 3 49 44 61 1 25 198 2 22 9
2023/2024286 15 23 5 23 8 21 80 4 4 14 22 67
2024/2025269 43 83 134 9 0 0 0 0 0 0 0 0
Totale 1.822